An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
about
HIV-1 Nef disrupts intracellular trafficking of major histocompatibility complex class I, CD4, CD8, and CD28 by distinct pathways that share common elementsRole of viral evolutionary rate in HIV-1 disease progression in a linked cohortLive attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaquesHIV-1 Transmission, Replication Fitness and Disease Progression.Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.Coreceptor usage, diversity, and divergence in drug-naive and drug-exposed individuals from Malawi, infected with HIV-1 subtype C for more than 20 years.Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo.Dynamics of physical interaction between HIV-1 Nef and ASK1: identifying the interacting motif(s).Human retroviruses after 20 years: a perspective from the past and prospects for their future control.Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemiasNef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.Immune-mediated attenuation of HIV-1A Genome-Wide Screen for Machinery Involved in Downregulation of MHC Class I by HIV-1 Nef.A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities.Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.In search of a function for the most frequent naturally-occurring length polymorphism (MFNLP) of the HIV-1 LTR: retaining functional coupling, of Nef and RBF-2, at RBEIII?HIV-1 Nef: at the crossroadsEpidemiologic characteristics and natural history of HIV-1 natural viral suppressors.Possible applications for replicating HIV 1 vectorsHIV immune evasion disruption of antigen presentation by the HIV Nef protein.Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.Modulation of HIV pathogenesis and T-cell signaling by HIV-1 NefHIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals.Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1.A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect.Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.
P2860
Q24602320-CA5D04C5-EBC2-42FE-B3F6-08F70318B9B2Q24815853-1F94FAB7-E144-4B36-A8C6-6DE1AC9F5164Q27305234-49FD7D6D-DBA7-46D1-81F7-05494AABAE6FQ33758570-AD9AF26F-F958-40EB-9F03-C4BA2AAC1F09Q33893395-AA948B57-75E1-4CA7-B5E2-B85550FC71E8Q34007084-B55E7FB1-B678-49D3-B2C0-88E2867FB8BAQ34269253-5819597F-DC39-4050-8340-4B20903DD939Q34301899-3AFF2160-3007-4CE3-A0BB-73B982B5B490Q34342429-97E23146-C25F-4401-80A5-4711FA67501EQ34717597-1D4DFF38-B48D-44FA-A295-A480A107BF70Q34782784-31F2E78D-2D6F-42FA-912A-5935C9D19137Q34792498-7D4BF52F-2260-4DD0-9CA6-9C178DD124C8Q35070255-1537F356-C76F-4855-A2C3-E57C6593520EQ35139327-80D1EE1C-F67E-41DD-A095-C08C20AD8261Q35798108-CE25FDD8-EE9F-45D0-AC1C-0009B7C7198FQ35806842-982D3127-7313-44BF-BCD0-74C36B04AB2EQ35877701-45D22657-F22C-433A-8FB6-AC34848A5542Q35948073-48E1379A-5605-4735-A601-6C95971EC1B4Q35995081-14ADBE17-5C96-4051-AE14-F1A102097C2AQ36499676-EA6DF03C-4321-41B7-A58A-2AFD6AA44165Q36858891-9CF86947-1DB1-4CB5-8190-487F0AA27EE4Q36926697-D6787958-728B-4F62-8490-0E699F50A6AAQ37230530-F93F5995-3CA2-4581-90D4-0505F0D3FA1BQ37768033-3F31A52A-FCB1-4232-8762-12D7D9BC1A56Q37901625-1A9C6EC4-00FD-4802-BAEE-50E0BECFFF93Q38814829-469818D0-C85E-4E8B-9D60-2E5ACDE28C4BQ39315703-E1EB8B62-68AD-408D-884C-D3AE0FB40425Q39577894-E5E1EEB7-F225-4A9B-98B6-1E5B914F8BC8Q39641516-9A816818-096C-496F-A604-CD4EFFD4B5CEQ39852042-F74CDAC0-732B-41E6-94C7-E460F06B8052Q40269589-B130B873-A7C6-4D3C-B267-3F1A6AB0EDC3Q40763168-204994F4-D5FF-4969-BA3B-0E4145D65EAAQ47817189-E7DC29CE-9B9B-437D-B5DB-73703202C075
P2860
An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@ast
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@en
type
label
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@ast
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@en
prefLabel
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@ast
An examination of signs of dis ...... dney Blood Bank Cohort (SBBC).
@en
P2093
P1476
An examination of signs of dis ...... ydney Blood Bank Cohort (SBBC)
@en
P2093
J C Learmont
J J Zaunders
J S Sullivan
N J Deacon
P304
P356
10.1016/S1386-6532(01)00198-6
P577
2001-10-01T00:00:00Z